Screening for untreated depression in cancer patients

A Japanese experience

Hironobu Inoguchi, Ken Shimizu, Haruki Shimoda, Kazuhiro Yoshiuchi, Tatsuo Akechi, Megumi Uchida, Asao Ogawa, Daisuke Fujisawa, Shinichiro Inoue, Yosuke Uchitomi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Guidelines for supportive care in cancer patients have recommended routine psychological screening in clinical practice, and a Japanese national project has recommended screening for depression using the Distress and Impact Thermometer. However, a previous study advocating the validity of the Distress and Impact Thermometer may have overestimated its effectiveness, as the study included already-treated patients who were not screening targets. This study reevaluated the performance and usefulness of the Distress and Impact Thermometer using an adequate sample size and appropriate study design. Methods: Patients were consecutively recruited at two highly specialized hospitals and three university hospitals in Japan. Inclusion criteria were (i) undergoing aggressive anti-cancer treatment, (ii) the Eastern Cooperative Oncology Group performance status score < 3 and (iii) age > 20 years. Patients who were receiving psychiatric treatment were excluded from the study. After completing the Distress and Impact Thermometer, patients were evaluated with the gold-standard Composite International Diagnostic Interview by researchers who were blinded to the patients' Distress and Impact Thermometer scores. Results: Forty-four patients (9%) who were receiving psychiatric treatment were excluded. Of 468 subjects included in the final analysis, only 3 had current depression (0.6%). Using cutoff points recommended by the previous study, the positive and negative predictive values were 0.02 and 0.99, respectively. Conclusions: Our data indicated that screening for untreated depression in cancer patients was not useful in the specific clinical settings that were studied, and such screening should be implemented in appropriate contexts. Since there are no evidence-based recommendations regarding contexts in which psychological screening is essential, further research is needed.

Original languageEnglish
Pages (from-to)993-999
Number of pages7
JournalJapanese Journal of Clinical Oncology
Volume46
Issue number11
DOIs
Publication statusPublished - 2016
Externally publishedYes

Fingerprint

Thermometers
Neoplasms
Psychiatry
Psychology
Gold
Sample Size
Japan
Therapeutics
Research Personnel
Guidelines
Interviews
Research

Keywords

  • Depression
  • Diagnosis
  • Neoplasms
  • Psycho-oncology
  • Questionnaires
  • Sensitivity and specificity

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Inoguchi, H., Shimizu, K., Shimoda, H., Yoshiuchi, K., Akechi, T., Uchida, M., ... Uchitomi, Y. (2016). Screening for untreated depression in cancer patients: A Japanese experience. Japanese Journal of Clinical Oncology, 46(11), 993-999. https://doi.org/10.1093/jjco/hyw104

Screening for untreated depression in cancer patients : A Japanese experience. / Inoguchi, Hironobu; Shimizu, Ken; Shimoda, Haruki; Yoshiuchi, Kazuhiro; Akechi, Tatsuo; Uchida, Megumi; Ogawa, Asao; Fujisawa, Daisuke; Inoue, Shinichiro; Uchitomi, Yosuke.

In: Japanese Journal of Clinical Oncology, Vol. 46, No. 11, 2016, p. 993-999.

Research output: Contribution to journalArticle

Inoguchi, H, Shimizu, K, Shimoda, H, Yoshiuchi, K, Akechi, T, Uchida, M, Ogawa, A, Fujisawa, D, Inoue, S & Uchitomi, Y 2016, 'Screening for untreated depression in cancer patients: A Japanese experience', Japanese Journal of Clinical Oncology, vol. 46, no. 11, pp. 993-999. https://doi.org/10.1093/jjco/hyw104
Inoguchi, Hironobu ; Shimizu, Ken ; Shimoda, Haruki ; Yoshiuchi, Kazuhiro ; Akechi, Tatsuo ; Uchida, Megumi ; Ogawa, Asao ; Fujisawa, Daisuke ; Inoue, Shinichiro ; Uchitomi, Yosuke. / Screening for untreated depression in cancer patients : A Japanese experience. In: Japanese Journal of Clinical Oncology. 2016 ; Vol. 46, No. 11. pp. 993-999.
@article{78b2d8de353f42d4ab96de3fff837a35,
title = "Screening for untreated depression in cancer patients: A Japanese experience",
abstract = "Objective: Guidelines for supportive care in cancer patients have recommended routine psychological screening in clinical practice, and a Japanese national project has recommended screening for depression using the Distress and Impact Thermometer. However, a previous study advocating the validity of the Distress and Impact Thermometer may have overestimated its effectiveness, as the study included already-treated patients who were not screening targets. This study reevaluated the performance and usefulness of the Distress and Impact Thermometer using an adequate sample size and appropriate study design. Methods: Patients were consecutively recruited at two highly specialized hospitals and three university hospitals in Japan. Inclusion criteria were (i) undergoing aggressive anti-cancer treatment, (ii) the Eastern Cooperative Oncology Group performance status score < 3 and (iii) age > 20 years. Patients who were receiving psychiatric treatment were excluded from the study. After completing the Distress and Impact Thermometer, patients were evaluated with the gold-standard Composite International Diagnostic Interview by researchers who were blinded to the patients' Distress and Impact Thermometer scores. Results: Forty-four patients (9{\%}) who were receiving psychiatric treatment were excluded. Of 468 subjects included in the final analysis, only 3 had current depression (0.6{\%}). Using cutoff points recommended by the previous study, the positive and negative predictive values were 0.02 and 0.99, respectively. Conclusions: Our data indicated that screening for untreated depression in cancer patients was not useful in the specific clinical settings that were studied, and such screening should be implemented in appropriate contexts. Since there are no evidence-based recommendations regarding contexts in which psychological screening is essential, further research is needed.",
keywords = "Depression, Diagnosis, Neoplasms, Psycho-oncology, Questionnaires, Sensitivity and specificity",
author = "Hironobu Inoguchi and Ken Shimizu and Haruki Shimoda and Kazuhiro Yoshiuchi and Tatsuo Akechi and Megumi Uchida and Asao Ogawa and Daisuke Fujisawa and Shinichiro Inoue and Yosuke Uchitomi",
year = "2016",
doi = "10.1093/jjco/hyw104",
language = "English",
volume = "46",
pages = "993--999",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Screening for untreated depression in cancer patients

T2 - A Japanese experience

AU - Inoguchi, Hironobu

AU - Shimizu, Ken

AU - Shimoda, Haruki

AU - Yoshiuchi, Kazuhiro

AU - Akechi, Tatsuo

AU - Uchida, Megumi

AU - Ogawa, Asao

AU - Fujisawa, Daisuke

AU - Inoue, Shinichiro

AU - Uchitomi, Yosuke

PY - 2016

Y1 - 2016

N2 - Objective: Guidelines for supportive care in cancer patients have recommended routine psychological screening in clinical practice, and a Japanese national project has recommended screening for depression using the Distress and Impact Thermometer. However, a previous study advocating the validity of the Distress and Impact Thermometer may have overestimated its effectiveness, as the study included already-treated patients who were not screening targets. This study reevaluated the performance and usefulness of the Distress and Impact Thermometer using an adequate sample size and appropriate study design. Methods: Patients were consecutively recruited at two highly specialized hospitals and three university hospitals in Japan. Inclusion criteria were (i) undergoing aggressive anti-cancer treatment, (ii) the Eastern Cooperative Oncology Group performance status score < 3 and (iii) age > 20 years. Patients who were receiving psychiatric treatment were excluded from the study. After completing the Distress and Impact Thermometer, patients were evaluated with the gold-standard Composite International Diagnostic Interview by researchers who were blinded to the patients' Distress and Impact Thermometer scores. Results: Forty-four patients (9%) who were receiving psychiatric treatment were excluded. Of 468 subjects included in the final analysis, only 3 had current depression (0.6%). Using cutoff points recommended by the previous study, the positive and negative predictive values were 0.02 and 0.99, respectively. Conclusions: Our data indicated that screening for untreated depression in cancer patients was not useful in the specific clinical settings that were studied, and such screening should be implemented in appropriate contexts. Since there are no evidence-based recommendations regarding contexts in which psychological screening is essential, further research is needed.

AB - Objective: Guidelines for supportive care in cancer patients have recommended routine psychological screening in clinical practice, and a Japanese national project has recommended screening for depression using the Distress and Impact Thermometer. However, a previous study advocating the validity of the Distress and Impact Thermometer may have overestimated its effectiveness, as the study included already-treated patients who were not screening targets. This study reevaluated the performance and usefulness of the Distress and Impact Thermometer using an adequate sample size and appropriate study design. Methods: Patients were consecutively recruited at two highly specialized hospitals and three university hospitals in Japan. Inclusion criteria were (i) undergoing aggressive anti-cancer treatment, (ii) the Eastern Cooperative Oncology Group performance status score < 3 and (iii) age > 20 years. Patients who were receiving psychiatric treatment were excluded from the study. After completing the Distress and Impact Thermometer, patients were evaluated with the gold-standard Composite International Diagnostic Interview by researchers who were blinded to the patients' Distress and Impact Thermometer scores. Results: Forty-four patients (9%) who were receiving psychiatric treatment were excluded. Of 468 subjects included in the final analysis, only 3 had current depression (0.6%). Using cutoff points recommended by the previous study, the positive and negative predictive values were 0.02 and 0.99, respectively. Conclusions: Our data indicated that screening for untreated depression in cancer patients was not useful in the specific clinical settings that were studied, and such screening should be implemented in appropriate contexts. Since there are no evidence-based recommendations regarding contexts in which psychological screening is essential, further research is needed.

KW - Depression

KW - Diagnosis

KW - Neoplasms

KW - Psycho-oncology

KW - Questionnaires

KW - Sensitivity and specificity

UR - http://www.scopus.com/inward/record.url?scp=85014322579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014322579&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyw104

DO - 10.1093/jjco/hyw104

M3 - Article

VL - 46

SP - 993

EP - 999

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 11

ER -